EFPIA Implementation and Analysis of Data

This webinar happened on 22 Nov, 2016
Dont worry if you missed it, we have it recorded for you.

On the 30th of June, 2016, pharmaceutical companies across Europe disclosed information about the financial interactions they had with HCPs during 2015 under the EFPIA Transparency Directive. With 33 member countries following the EFPIA disclosure code, many countries made several last minute changes to the original EFPIA reporting template for reporting purposes. Unlike the US Sunshine Act, there are several factors complicating the EFPIA requirements, including privacy laws in some countries that require consent given by the HCP for individual disclosure.

Join qordata as we partner with Dario Ghoddousi, VP Product Management, Compliance Solutions at QuintilesIMS to present a webinar ‘EFPIA Implementation and Analysis of Data’ on November 22nd, 2016 at 3 PM CET. Attendees of the webinar will receive an overview of the implementation of the EFPIA disclosure code, the discrepancies in reporting requirements of member countries and discuss areas of challenges and considerations along with important deadlines and reporting languages used across member countries. Further, Ned Mumtaz, qordata’s Practice Leader Life Science, will provide a detailed overview of reported EFPIA physician spend numbers, consent rates and the initiatives being taken by companies to increase the rate of consent. Hypothetical scenarios will be discussed to help highlight the real world challenges pharma companies face in this regard and how these may be averted in times to come.

The webinar promises to provide helpful information for employees at all levels of pharmaceutical companies, from Head of Compliance and Senior Counsel to Commercial Operations/Marketing.

Takeaway From This Webinar:

  • Insight to the implementation of the EFPIA transparency directive
  • Details of discrepancies in the reporting requirements of EU member countries
  • Information about reported EFPIA physician spend numbers
  • Insights to practices and strategies of pharma companies for managing transparency and disclosure reporting


  • Review implementation of EFPIA disclosure code in member countries
  • Discuss discrepancies in the reporting requirements of EU countries
  • Acquisition of consent and its results
  • Review consent rate in various EFPIA member countries
  • Deliberate upon physician spend details
  • Deliver insights into disclosure reporting practices of pharma companies in EU
  • Assess the initiatives companies can take to increase consent rates

Who Should Attend?

  • Head of Compliance
  • CCO
  • Director of Compliance (Transparency)
  • Senior Counsel
  • Manager Compliance
  • VP Compliance
  • VP Transparency
  • Compliance Analyst
  • Compliance Specialist
  • Commercial Operations/Marketing


Dario Ghoddousi
VP Product Management, Compliance Solutions

Co-Speaker & Moderator

Ned Mumtaz
Practice Leader Life Science